|
Epilepsy Part I - Columbia |
Epilepsy/Antiepileptic drug response algorithm |
Columbia University |
Case, Control |
2 |
244 |
|
|
|
CRF_Columbia |
Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) |
Columbia University |
Case Only |
2 |
|
|
|
|
caMRSA Implementation - Columbia |
caMRSA |
Columbia University |
Case, Control |
4 |
2,225 |
|
|
|
ADHD Implementation - Columbia |
ADHD phenotype algorithm |
Columbia University |
Case, Control |
5 |
1,294 |
|
|
|
Atopic Dermatitis - Columbia |
Atopic Dermatitis Algorithm |
Columbia University |
Case, Control |
7 |
238 |
|
|
|
RA_Columbia |
Rheumatoid Arthritis (RA) |
Columbia University |
Case, Control |
8 |
2,793 |
|
|
|
CAAD Implementation - Columbia |
CAAD (Carotid Artery Atherosclerosis Disease) |
Columbia University |
Case, Control |
9 |
1,530 |
|
|
|
Marshfield Zoster implementation |
Herpes Zoster |
Marshfield Clinic Research Foundation |
Case, Control |
10 |
10 |
100%, 100% |
|
|
Validation of Asthma algorithm - Geisinger |
Asthma |
Geisinger |
Case, Control |
10 |
10 |
100%, 100% |
|
|
CHOP implementation Case 3 |
Appendicitis |
|
Case Only |
10 |
|
50% |
|
|
AAA Implementation - Columbia |
Abdominal Aortic Aneurysm ( AAA ) |
Columbia University |
Case, Control |
10 |
1,354 |
|
|
|
CHOP NAFLD |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
CHOP |
Case Only |
12 |
|
100% |
|
|
Mayo CAAD cases and controls |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo |
Case, Control |
13 |
|
100% |
71% |
|
Appendicitis Case 1, Control |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case, Control |
15 |
20 |
93%, 100% |
|
|
Harvard Intellectual Disability |
Intellectual Disability |
|
Case, Control |
15 |
5,767 |
|
|
|
ACEi Cough Implementation - Columbia |
ACE Inhibitor (ACE-I) induced cough |
Columbia University |
Case, Control |
17 |
233 |
|
|
|
Columbia University - AFH Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Columbia University Medical Center |
Case, Control |
17 |
256 |
|
|
|
Columbia Implementation |
Ovarian/Uterine Cancer (OvUtCa) |
Columbia University |
Case, Control |
19 |
1,265 |
|
|
|
Geisinger c.Diff eMERGE3 Implementation |
Clostridium Difficile Colitis |
Geisinger |
Case, Control |
20 |
20 |
100%, 100% |
100%, 100% |
|
Appendicitis Implementation - Columbia |
Appendicitis |
Columbia University |
Case, Control |
21 |
3,038 |
|
|
|
Marshfield C-diff implementation |
Clostridium Difficile Colitis |
Marshfield Clinic Research Foundation |
Case, Control |
21 |
10 |
100%, 100% |
|
|
Epilepsy Phenotype Case and Control |
Epilepsy/Antiepileptic drug response algorithm |
KPWHRI |
Case, Control |
23 |
3,282 |
|
|
|
NAFLD Implementation_Columbia |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Columbia University |
Case, Control |
24 |
4,371 |
|
|
|
Geisinger Impl |
Colorectal Cancer (CRC) |
Geisinger |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Geisinger caMRSA Implementation |
caMRSA |
Geisinger |
Case, Control |
25 |
25 |
96%, 100% |
96% |
